PRISM: Patient Experiences With PET Imaging in Prostate Cancer

Recruiting

• Conditions: Prostate Cancer

• Registration Number: NCT06523777
• Lead Sponsor: Yale University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-7-22
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Inclusion Criteria:<br><br> - Documented diagnosis of prostate cancer<br><br> - Scheduled for their FIRST PSMA PET scan for prostate cancer<br><br> - English-speaking<br><br> - Willing and able to complete 4 surveys electronically or on paper at 3 timepoints<br> (within 1 month after PET scan, 3-6 months, 12 months)<br><br> - Able to use mobile device (smartphone or tablet) or computer with web access to<br> complete study surveys or able to complete paper surveys<br><br>Exclusion Criteria:<br><br> - Lack of access to a mobile device (smartphone or tablet) or computer with web access<br> or unable to receive surveys by mail.<br><br> - Unable to give consent and be enrolled<br><br> - PET scan is being conducted within a clinical trial

Exclusion Criteria

Not provided

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in Memorial Anxiety Scale for Prostate Cancer (MAX-PC);Change in Decisional Conflict Scale (DCS);Change in Expanded Prostate Cancer Index Composite Short Form (EPIC-26);Change in EuroQol-5 Dimension (EQ-5D)

Secondary Outcome Measures

Name	Time	Method
Qualitative interviews on patient experiences and perspectives on PET imaging.